Gluten and casein supplementation does not increase symptoms in children with autism spectrum disorder

Key Findings:  This study of children with autism spectrum disorder, (ASD) who were given gluten-casein or a placebo found that did not correlate to worsening gastrointestinal symptoms or maladaptive behaviors, and there was no difference in the urinary levels of intestinal fatty acids binding protein (I-FABP).

Type of Study:  Double Blind Clinical Trial

Study Sample Size:  74

Study Result:  Inconclusive

Study Location(s):  Belgium, Indonesia

Year of Pub:  2014

Cannabinoids Studied:  Fatty Acid-Binding Protein (FABP)

Phytocannabinoid Source:  Not Applicable

Route of Administration:  Endogenous

Link to study